U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5283152831Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 187004 in Patients With Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Placebo|Drug: BI 187004|Drug: BI 187004|Drug: BI 187004|Drug: BI 187004|Drug: BI 187004|Drug: BI 187004|Drug: BI 187004https://ClinicalTrials.gov/show/NCT01874483
5283252832Renal Denervation by Allegro System in Patients With Resistant HypertensionRecruitingNo Results AvailableRenal Denervation|Resistant Hypertension|Standard MedicationDevice: renal denervation|Other: standard medicationhttps://ClinicalTrials.gov/show/NCT01874470
5283352833Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)CompletedNo Results AvailableMumps|Rubella|MeaslesBiological: MMR (Mumps, Measles and Rubella)https://ClinicalTrials.gov/show/NCT01874457
5283452834Verify the Effectiveness rTMS Using MEGActive, not recruitingNo Results AvailableTinnitusDevice: 1|Device: 2|Device: 3|Device: 4https://ClinicalTrials.gov/show/NCT01874444
5283552835Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic NephropathyCompletedNo Results AvailableDiabetic NephropathiesDrug: Finerenone (BAY 94-8862)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01874431
5283652836Biomarker Study to Diagnose Alzheimer's DiseaseRecruitingNo Results AvailableAlzheimer Disease|Mild Cognitive ImpairmentOther: Biomarkerhttps://ClinicalTrials.gov/show/NCT01874418
5283752837Retrospective Evaluation of Adult and Pediatric Transfusion-dependent Patients Treated With Deferasirox TherapyCompletedNo Results AvailableIron Overloadhttps://ClinicalTrials.gov/show/NCT01874405
5283852838Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind CorpCompletedNo Results AvailableType 1 Diabetes MellitusDrug: Investigational inhaled insulin (Technosphere)|Device: Artificial Pancreas (AP) device (APS©)https://ClinicalTrials.gov/show/NCT01874392
5283952839'M'-Technique, Guided Imagery, or Standard of Care on Anxiety and Pain Pre- & Post-operatively in Elective Joint Replacement PatientsRecruitingNo Results AvailableHip or Knee ReplacementOther: 'M'-Technique®|Other: Guided Imagery|Other: Standard of Carehttps://ClinicalTrials.gov/show/NCT01874379
5284052840Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187RecruitingNo Results AvailableOverweight|Diabetes Mellitus Type 2 in ObeseDrug: P11187|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01874366
5284152841Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum ChemotherapyRecruitingNo Results AvailablePlatinum Sensitive|BRCA Mutated|Relapsed Ovarian Cancer|Following Complete or Partial Response to Platinum Based ChemotherapyDrug: Olaparib 300mg tablets|Drug: Placebo to match olaparib 300mghttps://ClinicalTrials.gov/show/NCT01874353
5284252842Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple SclerosisTerminatedHas ResultsMultiple SclerosisDrug: Placebo|Drug: AIN457https://ClinicalTrials.gov/show/NCT01874340
5284352843Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)RecruitingNo Results AvailableChildren at Risk for ASDBehavioral: Baby JASPER|Behavioral: Standard Baby Classroomhttps://ClinicalTrials.gov/show/NCT01874327
5284452844Effects of SQ109 on QTc Interval in Healthy SubjectsWithdrawnNo Results AvailableTuberculosisDrug: SQ109|Other: SQ109 Placebo|Drug: Moxifloxacinhttps://ClinicalTrials.gov/show/NCT01874314
5284552845Probiotics and Gut HealthRecruitingNo Results AvailableConstipationOther: High quantity probiotic|Other: Low quantity probiotic|Other: placebohttps://ClinicalTrials.gov/show/NCT01874301
5284652846Phase I/II Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered Subcutaneously in Patients With B-cell NHLRecruitingNo Results AvailableB-cell Non-Hodgkin LymphomaDrug: 0.5 mg/m2 DI-Leu16-IL2|Drug: 1.0 mg/m2 DI-Leu16-IL2|Drug: 2.0 mg/m2 DI-Leu16-IL2|Drug: 4.0 mg/m2 DI-Leu16-IL2|Drug: 6.0 mg/m2 DI-Leu16-IL2|Drug: 8.0 mg/m2 DI-Leu16-IL2|Drug: 10.0 mg/m2 DI-Leu16-IL2https://ClinicalTrials.gov/show/NCT01874288
5284752847Duchenne Muscular Dystrophy Clinical TrialCompletedHas ResultsDuchenne Muscular DystrophyDevice: VECTTORhttps://ClinicalTrials.gov/show/NCT01874275
5284852848A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial InfarctionCompletedNo Results AvailableMyocardial InfarctionDevice: Mobile-phone based patient support|Device: e-diaryhttps://ClinicalTrials.gov/show/NCT01874262
5284952849Non Invasive Assessment of Liver Fibrosis in Fatty Liver DiseaseActive, not recruitingNo Results AvailableNon Alcoholic Fatty Liver DiseaseOther: Electronic detailed information|Other: NAFLD Score|Other: Transient elastographyhttps://ClinicalTrials.gov/show/NCT01874249
5285052850Validity and Reliability of Diagnostic Findings of SI Joint BlockingTerminatedNo Results AvailableSI Joint PainDrug: 0.75% bupivacaine|Drug: .75% bupivacaine|Drug: .75% bupivacainehttps://ClinicalTrials.gov/show/NCT01874236
5285152851Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)Not yet recruitingNo Results AvailableInterstitial Lung Disease|Idiopathic Pulmonary Fibrosishttps://ClinicalTrials.gov/show/NCT01874223
5285252852Study on Colonic Fermentation in Chronic Kidney Disease PatientsRecruitingNo Results AvailableRenal Insufficiency, Chronichttps://ClinicalTrials.gov/show/NCT01874210
5285352853Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal AorticRecruitingNo Results AvailableThoracoabdominal Aortic Aneurysm, Without RuptureDevice: B-TEVAR devicehttps://ClinicalTrials.gov/show/NCT01874197
5285452854Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast CancerActive, not recruitingNo Results AvailableAtypical Ductal Breast Hyperplasia|Atypical Lobular Breast Hyperplasia|BRCA1 Mutation Carrier|BRCA2 Mutation Carrier|Ductal Breast Carcinoma in Situ|Lobular Breast Carcinoma in SituOther: counseling intervention|Behavioral: behavioral dietary intervention|Behavioral: exercise intervention|Other: questionnaire administration|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01874184
5285552855Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCCRecruitingNo Results AvailableOropharyngeal Squamous Cell CarcinomaDrug: Cisplatin|Drug: Cetuximabhttps://ClinicalTrials.gov/show/NCT01874171
5285652856DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative WomenCompletedNo Results AvailableTrichomonas Vaginitishttps://ClinicalTrials.gov/show/NCT01874158
5285752857Safety and Tolerability of Glatiramer AcetateCompletedNo Results AvailableRelapsing-Remitting Multiple SclerosisDrug: GA 20 mg/mL|Drug: GA 40 mg/mLhttps://ClinicalTrials.gov/show/NCT01874145
5285852858Study of the Long-term Effects of Exercise on Heath Indicators in Older PeopleCompletedNo Results AvailableHypertension With Complications and Secondary Hypertension|Overweight and Obesity|Lipid Metabolism Disorders|Sarcopenia|Osteoporosis|Personal SatisfactionBehavioral: Exercise traininghttps://ClinicalTrials.gov/show/NCT01874132
5285952859Fosaprepitant for Nausea and Vomiting During High-dose Interleukin-2 (HD IL-2) for Metastatic Melanoma and Renal Cell CarcinomaRecruitingNo Results AvailableChemotherapy-induced Nausea and VomitingDrug: Fosaprepitanthttps://ClinicalTrials.gov/show/NCT01874119
5286052860Effect of Anti-inflammatory Diet on Inflammatory, Oxidative and Nutritional Markers in Hemodialysis PatientsCompletedNo Results AvailableInflammation|Malnutrition|Protein Energy Wasting Syndrome|Oxidative Stress|Diet TherapyOther: Diet Therapy|Other: Control Grouphttps://ClinicalTrials.gov/show/NCT01874106

* Görseller ve İçerik tekif hakkına sahip olabilir